David G. DeNardo
Impact in
- Immunology top 0.1%
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Phagocytosis and Immune Regulation
- Oncology top 0.1%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Pancreatic and Hepatic Oncology Research
Papers in
- Oncology 58
- Cancer Immunotherapy and Biomarkers 34
- Pancreatic and Hepatic Oncology Research 22
- Cancer Cells and Metastasis 7
- Immunology 58
- Immune cells in cancer 45
- Immunotherapy and Immune Responses 18
- Immune Cell Function and Interaction 12
- Phagocytosis and Immune Regulation 7
- Co-authors
- Brian Ruffell (7 shared papers)Lisa M. Coussens (16 shared papers)Brett L. Knolhoff (23 shared papers)Pauline Andreu (3 shared papers)David C. Linehan (13 shared papers)Andrea Wang‐Gillam (21 shared papers)Yu Zhu (7 shared papers)Brian L. West (3 shared papers)
- Journals
- Cancer Research (17 papers)Journal of Clinical Oncology (8 papers)Cancer Cell (6 papers)Cancer Discovery (4 papers)Clinical Cancer Research (4 papers)
- Partner nations
- United StatesGermanyIreland
In The Last Decade
David G. DeNardo
108 papers receiving 15.5k citations
David G. DeNardo's Hit Papers
Peers
Comparison fields: 5 of 131
- Immunology 8.5k
- Oncology 7.8k
- Cancer Research 2.0k
- Immunology and Allergy 374
- Molecular Biology 4.1k
Countries citing papers authored by David G. DeNardo
This map shows the geographic impact of David G. DeNardo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David G. DeNardo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David G. DeNardo more than expected).
Fields of papers citing papers by David G. DeNardo
This network shows the impact of papers produced by David G. DeNardo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David G. DeNardo. The network helps show where David G. DeNardo may publish in the future.
Co-authors
The 25 scholars most cited alongside David G. DeNardo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 113 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Macrophages as regulators of tumour immunity and immunotherapy Hit paper breakdown → | 2019 | 1760 |
| 2 | Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy Hit paper breakdown → | 2011 | 1325 |
| 3 | CD4+ T Cells Regulate Pulmonary Metastasis of Mammary Carcinomas by Enhancing Protumor Properties of Macrophages Hit paper breakdown → | 2009 | 1065 |
| 4 | CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Models Hit paper breakdown → | 2014 | 992 |
| 5 | Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy Hit paper breakdown → | 2016 | 771 |
| 6 | Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses Hit paper breakdown → | 2012 | 768 |
| 7 | Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression Hit paper breakdown → | 2017 | 600 |
| 8 | Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression Hit paper breakdown → | 2007 | 541 |
| 9 | Macrophage Expression of Hypoxia-Inducible Factor-1α Suppresses T-Cell Function and Promotes Tumor Progression Hit paper breakdown → | 2010 | 530 |
| 10 | Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis Hit paper breakdown → | 2013 | 486 |
| 11 | 2010 | 441 | |
| 12 | 2010 | 376 | |
| 13 | 2017 | 372 | |
| 14 | 2016 | 357 | |
| 15 | 2020 | 307 | |
| 16 | 2007 | 291 | |
| 17 | 2011 | 251 | |
| 18 | 2015 | 208 | |
| 19 | 2009 | 189 | |
| 20 | 2014 | 188 |
About David G. DeNardo
David G. DeNardo is a scholar working on Oncology, Immunology, Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 113 papers that have together received 15.7k indexed citations. Recurring topics across this work include Immune cells in cancer (45 papers), Cancer Immunotherapy and Biomarkers (34 papers), Pancreatic and Hepatic Oncology Research (22 papers), Immunotherapy and Immune Responses (18 papers), Immune Cell Function and Interaction (12 papers), Cancer Cells and Metastasis (7 papers), Phagocytosis and Immune Regulation (7 papers) and Epigenetics and DNA Methylation (6 papers). The work is most often cited by research in Immunology (8.5k citations), Oncology (7.8k citations), Cancer Research (2.0k citations), Immunology and Allergy (374 citations) and Molecular Biology (4.1k citations). David G. DeNardo has collaborated with scholars based in United States, Germany and Ireland. Frequent co-authors include Brian Ruffell, Lisa M. Coussens, Brett L. Knolhoff, Pauline Andreu, David C. Linehan, Andrea Wang‐Gillam, Yu Zhu, Brian L. West, Timothy M. Nywening and Magnus Johansson. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Cancer Cell, Cancer Discovery and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.